Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial.
"Today is an important day for us, country and Indian science.
COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial.
The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.
Union Health Minister Harsh Vardhan and his wife Nutan Goel took the second dose of Covid-19 vaccine. Harsh Vardhan and his wife..
Prime Minister Narendra Modi took a Covid shot this morning at Delhi's AIIMS hospital, becoming the first beneficiary in the second..
Prime Minister Narendra Modi took his first dose of COVID-19 vaccine at AIIMS Delhi on March 01. Sister P Niveda, from Puducherry,..
